FDA Adverse Event Injury Summary report: N

ONE TOUCH LANCING DEVICE

MDR report key: 2020830 · Received March 16, 2011

Report

Report Number
2939301-2011-02297
Event Type
Injury
Date Received
March 16, 2011
Report Date
February 28, 2011
Manufacturer
LIFESCAN INC.
Product Code
NBW
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

LIFESCAN (LFS) HAS REQUESTED RETURN OF THE SUBJECT PRODUCT(S) FOR EVALUATION. IF THE PRODUCT(S) ARE RETURNED, LFS WILL EVALUATE IT/THEM AND INFORM FDA OF PRODUCT(S) THAT DO NOT PASS INSPECTION IN A SUPPLEMENTAL REPORT.

Description of Event or Problem · 1

ON (B)(6) 2011, THE LAY USER/PATIENT CONTACTED LIFESCAN (LFS) ALLEGING AN UNKNOWN ONETOUCH LANCING DEVICE WAS NOT PENETRATING HER FINGER. THE COMPLAINT WAS CLASSIFIED BASED ON THE CUSTOMER CARE ADVOCATE (CCA) DOCUMENTATION. THE PATIENT REPORTED THE ALLEGED ISSUE BEGAN LAST YEAR AT AN UNKNOWN DATE/TIME PRIOR TO CONTACTING LFS. AS PART OF HER DIABETES REGIMEN, THE PATIENT INDICATED SHE IS ON ORAL MEDICATIONS OF GLIPIZIDE PILLS 3X DAILY. DUE TO THE ALLEGED ISSUE, THE PATIENT STATED SHE ADMINISTERED ONLY 2 PILLS INSTEAD OF 3. A FEW MINUTES AFTER THE ALLEGED ISSUE BEGAN, THE PATIENT WAS FEELING STRESSED. AS A RESULT OF THE ALLEGED ISSUE, THE PATIENT INDICATED SHE WAS TAKEN TO THE EMERGENCY ROOM (ER) FOR ASSISTANCE. ACCORDING TO THE PATIENT, SHE WAS TESTED WITH A "38 MG/DL" READING BY THE ER/HOSPITAL METER AND WAS THEN ADMINISTERED "SUGAR SHOT" AND AN UNKNOWN DRINK TO RAISE HER BLOOD SUGAR LEVELS. AT THE TIME OF TROUBLESHOOTING, THE CCA WAS NOT ABLE TO RESOLVE THE ALLEGED ISSUE. REPLACEMENT PRODUCT WAS SENT TO THE PATIENT. THIS COMPLAINT IS BEING REPORTED BECAUSE THE PATIENT ALLEGEDLY RECEIVED MEDICAL INTERVENTION FROM A HEALTH CARE PROFESSIONAL (HCP) AFTER THE REPORTED ISSUE BEGAN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ONE TOUCH LANCING DEVICE GLUCOSE MONITORING SYS/KIT NBW LIFESCAN INC.

Patients

Seq Age Sex Outcome Treatment
1 52 YR Required Intervention